Full-Time

Bioinformatician

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Accelerates antibody drug discovery with data science

Data & Analytics
AI & Machine Learning
Biotechnology

Mid

Vancouver, BC, Canada

Required Skills
Python
Requirements
  • PhD or MSc in Bioinformatics, Computational Biology, or a related field, or a BSc with at least three years of relevant work experience
  • Demonstrated expertise in Python and building code in a collaborative environment
  • Experience supporting and working with cross-functional teams in a dynamic environment
  • Experience working with high-throughput sequencing data
  • Strong analytical skills related to working with unstructured datasets
  • A demonstrated ability to find creative and functional solutions to complicated problems
  • The ability to express complex ideas in understandable ways, and to communicate effectively with people from different fields
  • Excellent documentation skills with impeccable attention to detail
Responsibilities
  • Analyze sequencing data generated as part of our antibody discovery programs
  • Develop and extend bioinformatics pipelines for analyzing single-cell and bulk immunoglobulin repertoire sequencing data
  • Help integrate our pipelines with other components of AbCellera’s tech stack
  • Work with scientists on our discovery teams to explore datasets of therapeutic candidates
  • Collaborate with wet-lab scientists, data scientists, and bioinformaticians to design experiments, analyze data, and interpret results in order to improve and develop new technologies for antibody discovery and engineering
Desired Qualifications
  • A good foundation in statistical analysis
  • An understanding of the basics and limitations of experimental protocols
  • A background in immunobiology

AbCellera stands out as a leader in the biotech industry due to its unique approach to antibody drug discovery, combining expert teams, advanced technology, and data science to expedite the process from target to clinic across various therapeutic areas. The company's competitive edge lies in its ability to enable swift progress, cost reduction, and problem-solving in drug development for both innovative biotechs and leading pharmaceutical companies. Furthermore, AbCellera's commitment to technical innovation is evident in its recent presentation of new data on two T-Cell Engager Programs at SITC 2023, demonstrating its active role in advancing the field.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

16%

2 year growth

77%
INACTIVE